FOXD3 is a putative tumor suppressor that affects growth, invasion, metastasis, and angiogenesis of a number of cancers, including neurobastoma 26, breast cancer 27, gastric cancer 28, and the deficiency of FOXD3 expression is linked to their malignant phenotypes. Here, FOXD3 is linked to neoplasm.